FDA Urged To Articulate Policy On Clinical Decision Support Software
This article was originally published in The Gray Sheet
Executive SummaryThe topic of clinical decision support software does not belong in FDA guidance on mobile health applications and should be addressed, as soon as possible, in separate guidance, stakeholders say.
You may also be interested in...
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.